185 Endomorphins and activation of the hypothalamo–pituitary–adrenal axis T L Coventry, D S Jessop, D P Finn, M D Crabb, H Kinoshita and M S Harbuz University Research Centre for Neuroendocrinology, University of Bristol, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK (Requests for offprints should be addressed to M S Harbuz; Email:
[email protected]) Abstract Endomorphin (EM)-1 and EM-2 are opioid tetrapeptides unaffected by either morphine or endomorphins. Since recently located in the central nervous system and immune release of other opioids are elevated in response to acute tissues with high selectivity and affinity for the µ-opioid stress, we exposed rats to a range of stressors to determine receptor. Intracerebroventricular (i.c.v.) administration of whether plasma EM-1 and EM-2 can be stimulated by morphine stimulates the hypothalamo–pituitary–adrenal HPA axis activation. Plasma corticosterone, ACTH and (HPA) axis. The present study investigated the effect of -endorphin were elevated following acute restraint stress, centrally administered EM-1 and EM-2 on HPA axis but concentrations of plasma EM-1-immunoreactivity (ir) activation. Rats received a single i.c.v. injection of either and EM-2-ir did not change significantly. Corticosterone, EM-1 (0·1, 1·0, 10 µg), EM-2 (10 µg), morphine (10 µg), ACTH and -endorphin were further elevated in or vehicle (0·9% saline). Blood samples for plasma cortico- adjuvant-induced arthritis (AA) rats by a single injection of sterone determinations were taken immediately prior to lipopolysaccharide (LPS), but not by restraint stress.